Xvivo Perfusion AB (publ)
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a XVIPF research report →
Price Chart
About the company
Xvivo Perfusion AB (publ) is a medical technology company dedicated to advancing transplantation medicine. The firm specializes in pioneering solutions for the preservation and perfusion of organs, tissues, and cells, essential for successful transplant procedures. With a significant international presence, Xvivo Perfusion operates across diverse markets, including Sweden, the United States, wider North and South America, Europe, the Middle East, Africa, and the Asia Pacific region.
- CEO
- Christoffer Rosenblad
- IPO
- 2014
- Employees
- 210
- HQ
- Mölndal, VG, SE
Get TickerSpark's AI analysis on XVIPF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $686.69M
- P/E
- 74.16
- Fwd P/E
- 6.43
- PEG
- -3.60
- P/S
- 7.33
- P/B
- 2.98
- EV/EBITDA
- 33.68
- Div Yield
- 0.00%
- Gross Margin
- 62.85%
- Op Margin
- 12.66%
- Net Margin
- 9.89%
- ROE
- 4.13%
- ROIC
- 3.25%
Latest fiscal year · YoY change
- Revenue
- $810.13M-1.5%
- Gross Profit
- $532.16M-13.7%
- Op Income
- $92.78M
- Net Income
- $25.10M-85.4%
- EPS
- $0.80-85.4%
- OCF Growth
- -9.4%
- FCF Growth
- -474.4%
- 52W High
- $30.95
- 52W Low
- $16.98
- 50D MA
- $27.26
- 200D MA
- $24.93
- Beta
- 1.46
- RSI (14)
- 13
- Avg Volume
- 105
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Get the XVIPF Q2 '26 earnings-call summary
Create a free account to generate an AI summary of this call — key takeaways, results & guidance, CEO/CFO commentary, Q&A, and a bull vs bear read. Ready in about a minute, and it'll be live for everyone.
Create free account →Already have an account? Log in
- Free Float
- 79.8%
- Shares Outstanding
- 31.50M
- Float Shares
- 25.13M
Our XVIPF coverage
Recent articles, reports, and earnings notes.
No research on XVIPF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate XVIPF report →Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.